SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma informs about updates on Book Closure

26 Aug 2014 Evaluate

With reference to the earlier announcement dated August 20, 2014, regarding Book Closure from September 08, 2014 to September 12, 2014 for the Final Dividend & AGM, Anuh Pharma has now informed that the said Book Closure from September 08, 2014 to September 12, 2014 also for the purpose of Payment of Interim Dividend.

The above information is a part of company’s filings submitted to BSE.

 

Anuh Pharma Share Price

81.48 0.38 (0.47%)
21-Apr-2026 12:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.80
Dr. Reddys Lab 1221.40
Cipla 1232.90
Zydus Lifesciences 927.00
Lupin 2322.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×